Home / Resource Library / Rituximab plus lenalidomide (R2) versus standard therapies in follicular lymphoma: A systematic review and meta-analysis of randomized controlled trials
Rituximab plus lenalidomide (R2) versus standard therapies in follicular lymphoma: A systematic review and meta-analysis of randomized controlled trials